Senzar Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-415,200
Closed -$34.2M 33
2017
Q2
$34.2M Buy
+415,200
New +$33.9M 8.41% 5
2017
Q1
Sell
-547,405
Closed -$40.3M 31
2016
Q4
$40.3M Buy
547,405
+112,905
+26% +$8.41M 10.68% 2
2016
Q3
$34.9M Sell
434,500
-167,300
-28% -$13.4M 9.02% 2
2016
Q2
$47.4M Buy
+601,800
New +$45.3M 10.33% 1
2015
Q2
Sell
-306,500
Closed -$22.3M 41
2015
Q1
$22.3M Buy
+306,500
New +$21.8M 5.43% 6

Other funds holding LLY

Senzar Asset Management's LLY Position: Q3 2017 in Review

Senzar Asset Management sold out of Eli Lilly (LLY) in Q3 2017, closing a stake of 415,200 shares — an estimated $34.2M sold.

Senzar Asset Management first reported a position in LLY in Q1 2015 and held it in 5 quarters. The position peaked at $47.4M in Q2 2016. 1,228 funds tracked by Wall St. Rank hold LLY as of Q3 2017.

  • Senzar Asset Management reported no remaining Eli Lilly position as of Q3 2017 after selling out during the quarter.
  • Senzar Asset Management sold 415,200 Eli Lilly shares in Q3 2017, an estimated $34.2M.
  • Senzar Asset Management first reported a position in Eli Lilly in Q1 2015 and held it in 5 quarters.
  • Senzar Asset Management's Eli Lilly position peaked at $47.4M in Q2 2016.
  • 1,228 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2017.

Based on Senzar Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.